bioRxivImmunology
Induction of immortal-like and functional CAR-T cells by defined factors
L. Wang, G. Jin, Q. Zhou, Y. Liu, X. Zhao, Z. Li, N. Yin, M. Peng
Abstract
Long-term antitumor efficacy of chimeric antigen receptor (CAR)-T cells depends on their functional persistence in vivo. T cells with stem-like property show better persistence, but factors conferring T cells bona fide stemness remain to be determined. Here, we demonstrate the induction of CAR-T cells into an immortal-like and functional state, termed TIF. The induction of CAR-TIF cells depends on repression of two factors: BCOR and ZC3H12A, and requires antigen or CAR tonic signaling. The reprogrammed CAR-TIF cells possess almost infinite stemness resembling induced pluripotent stem cells but retain functionality of mature T cells, which exhibit superior antitumor effect. CAR-TIF cells enter a metabolically dormant state after elimination of target cells, which persist in vivo with a saturable niche and mediate memory protection. CAR-TIF cells represent a novel state of T cells with unprecedented stemness conferring long-term functional persistence of CAR-T cells in vivo, which have broad potentials in T cell therapies.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting ZC3H12C improves T cell persistence and antitumor function in adoptive T cell therapy
Gayatri Kavishwar, Markus Perl, … Christian Schmidl·bioRxiv·May 2, 2026
- Transient "rest" induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells
E. W. Weber, R. C. Lynn, … C. L. Mackall·bioRxiv·Jan 26, 2020
- CTLA-4 tail fusion enhances CAR-T anti-tumor immunity
- BACH2 dosage establishes the hierarchy of stemness and finetunes antitumor immunity in CAR T cells
Taidou Hu, Ziang Zhu, … Tuoqi Wu·Nature ImmunologyPeer-reviewed·Jan 16, 2026
- Decade-long remissions of leukemia sustained by the persistence of activated CD4+ CAR T-cells
J. J. Melenhorst, G. M. Chen, … C. H. June·bioRxiv·May 7, 2021
- Dendritic cells accelerate CAR T cells in irradiated tumors through chimeric synapses
Sammy Navarre, Maki Ishibashi, … Jalal Uddin Ahmed·Nature CancerPeer-reviewed·May 22, 2026